UPSTREAM BIO INC. - COMMON STOCK

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 мар 2025 06:00:00 Источник Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 фев 2025 07:00:01 Источник Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 07:00:01 Источник Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 дек 2024 07:00:04 Источник Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 ноя 2024 06:00:01 Источник Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 окт 2024 15:15:00 Источник Nasdaq GlobeNewswire